Interim results from the preliminary analysis of the JAVELIN-Renal 101 trial suggest that adding immunotherapy to a targeted agent appears to significantly improve progression-free survival (PFS) when compared with a…
Genetic testing for Parkinson’s risks can be useful to people with and without the disease. It can also help advance research into the complex condition. Although the testing…
In the largest prospective study of angiogenesis in metastatic renal cell carcinoma (mRCC) patients to date, an Italian study yielded data that suggests sorafenib had no meaningful impact…
Results from a retrospective study in Lancet Neurology reveal that high concentrations of neurofilament light proteins (NfLs) in blood plasma of HTT gene mutation carriers can predict clinical…
According to Lars Brouwers, MD, MSc, a physician and PhD-candidate performing research on 3D-printing in the hospital environment, when doctors use traditional x-ray and 2DCT diagnostic tools in…
Scientists take aim at developing a single therapeutic intervention to achieve sustained clotting factor levels adequate enough to prevent bleeding in patient with hemophilia B without needing to…
Millions of people worldwide suffer from Hepatitis C. Viekira Pak and Harvoni are both prescription drugs used to treat Hepatitis C. Harvoni is a combination of two drugs:…
According to doctors, the non-compliance by patients towards their medication results in a loss of over $100 billion, which could be diverted to other areas of healthcare and…
